The Australian scientists from Monash University and Royal Hospital in Melbourne found out that anti-parasitic of broad-spectrum – ivermectin – might suppress the presence of coronavirus in body cells during two days, as Antiviral Research reported.
“Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect ∼5000-fold reduction in viral RNA at 48 h,” the scientists reported.
The experiments were held to Vero-hSLAM cells. Scientists should find out whether the drug may fight against coronavirus in human body.
Ivermectin is used for the treatment of the number of endoparasitic and ectoparasitic diseases of humans and different animals. Particularly, for the treatment of scabies, pediculosis, helminthiasis, and myiasis. The drug transmission of nerve impulses of a parasite and it leads to its death.
Ivermectin is approved by the Food and Drug Administration of the U.S. (FDA). Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.
Earlier, the WHO announced the start of testing of the vaccine against SARS-Cov-2 coronavirus.